Sana Klinikum Hof GmbH
- Address
- Eppenreuther Strasse 9, Innenstadt, 95032 Hof, Germany
Sana Klinikum Hof GmbH - Colorectal Cancer Research Center
Sana Klinikum Hof GmbH is actively engaged in advancing the treatment paradigm for colorectal malignancies through participation in innovative clinical research. The center specializes in studying optimal therapeutic sequencing and timing strategies for patients with locally advanced disease, contributing to multi-center trials that aim to redefine standard-of-care approaches.
- Advanced colon cancer treatment strategies and surgical timing optimization
- Preoperative systemic chemotherapy in resectable colorectal tumors
- Stage-guided adjuvant therapy protocols for node-positive disease
The institution focuses particularly on T3-4 stage colon cancer and node-positive disease, investigating whether preoperative chemotherapy delivered before surgical resection offers superior outcomes compared to the traditional approach of surgery followed by adjuvant therapy. This research addresses a critical question in oncology regarding the optimal treatment sequence for patients with locally advanced but non-metastatic colon cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sana Klinikum Hof GmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III Trial on Preoperative Chemotherapy with Irinotecan, Oxaliplatin, and Capecitabine in Resectable Advanced Colon Cancer | Charite Universitaetsmedizin Berlin KöR | Phase III | Recruiting | Apr 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Calcium Folinate | 1 | Unknown | 2025-04-01 | 2025-04-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.